LDC has exited Lucid Group, the international healthcare communications group, to Intermediate Capital Group (ICG).
London-headquartered Lucid Group provides medical education and communication, strategic consultancy and digital services to its clients through an integrated group of specialist agencies. The firm, which employs more around 250 staff across the UK, US and international offices, works with the world’s leading pharmaceutical brands to improve both disease management and patient outcomes.
Dennis O’Brien, CEO of Lucid Group, said: “This marks the start of an exciting new chapter for Lucid, which drives increased investment to help us realise our vision of transforming lives. We have a tremendous team and a great client base, our goal is to continue to strengthen this by bringing new capabilities and more value to our partnerships. With ICG we feel we have the perfect partner who shares our vision and matches our level of ambition to transform the value we bring to our industry and to patients. ICG are deeply committed to investing in this sector and are perfectly positioned to help bring the best capabilities to our business and support us to further internationalise.”
Peter Kirtley, ICG’s managing director, added: “ICG is a leading global alternative asset manager, with a long and successful track record of providing capital to support founder-led growing businesses like Lucid Group. We have admired Lucid Group and its reputation within the industry for many years. Through our partnership, together, we can leverage Lucid’s ambition and our sector expertise to build a truly global healthcare communications organisation.”
